• Department of Anesthesiology, General Hospital of Guangzhou Military Command of PLA, Guangzhou 510010, China;
ZHANG Xingan, Email: zhangxingan01@gmail.com
Export PDF Favorites Scan Get Citation

Objective  To systematically review the clinical effectiveness and safety of sufentanil-propofol versus remifentanil-propofol during total intravenous anesthesia for neurosurgery.
Methods  Databases including The Cochrane Library (Issue 3, 2013), the database of the Cochrane Anesthesia Group, MEDLINE, EMbase, PubMed, Ovid, Springer, CNKI, VIP and WanFang Data were electronically searched from inception to May 2013 for the randomized controlled trials (RCTs) of sufentanil-propofol versus remifentanil-propofol during total intravenous anesthesia for neurosurgery. Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data, and assessed the quality of included studies. Then, meta-analysis was performed using RevMan 5.1 software.
Results  Thirteen trials involving 647 patients were finally included. The results of meta-analysis showed that: a) for hemodynamic changes, MAP decreased in the remifentanil-propofol group after induction and decreased 5 minutes after intubation, but no significant difference was found between the two groups; the two groups were alike in MAP changes during craniotomy and extubation, and in HR changes after induction, 5 minutes after intubation, during craniotomy and extubation, with no significant difference. b) The result of intra-operative wake-up test showed that, there was no significant difference in the sedative effect and the time of awaking between the two groups. c) For emergence time and extubation time, compared with the sufentanil-propofol group, emergence time and extubation time were significantly shorter than those in the remifentanil-propofol group. d) For side effects, there was no significant difference in side effects (such as post-operative nausea, vomiting, respiratory depression, restlessness, chills and hypotension) between the two groups. And e) for post-operative pain, compared with the remifentanil-propofol group, post-operative 1-h and 2-h VAS were lower and the number of who need additional analgesic drugs within 24 h after operation was less in the sufentanil-propofol group, with significant differences. Both groups used the similar dosage of propofol with no significant difference.
Conclusion  Compared with the remifentanil-propofol group, hemodynamics changes in the sufentanil-propofol group is steadier after induction and during intubation. Patients in the sufentanil-propofol group are better in postoperative awakening quality. But they are alike in the incidence of side effects and propofol dosage.

Citation: YANG Tingting,TANG Yiyang,ZHANG Xingan. Effectiveness and Safety of Sufentanil-Propofol versus Remifentanil-Propofol During Total Intravenous Anesthesia for Neurosurgery: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2013, 13(12): 1492-1499. doi: 10.7507/1672-2531.20130254 Copy

  • Previous Article

    Risk Factors of Secondary Tricuspid Regurgitation: A Meta-Analysis
  • Next Article

    Increasing Protocol Design is the Cornerstone for Overall Improvement of Clinical Trials